首页> 外文期刊>National Journal of Medical Research >Comparison of Oral and Laryngeal Findings of Asthma Patients Using Different Dry Powder Inhaler Devices Containing Steroid and Beta Agonists
【24h】

Comparison of Oral and Laryngeal Findings of Asthma Patients Using Different Dry Powder Inhaler Devices Containing Steroid and Beta Agonists

机译:使用含有类固醇和β激动剂的干粉吸入器对哮喘患者的口腔和喉部发现进行比较

获取原文
       

摘要

Objective: In this study, we aimed to compare the oral and laryngeal findings of asthma patients using different dry powder inhalers (DPI) containing corticosteroid and long-acting beta-2 agonists. Methods: This study included 109 asthmatics who were divided into 3 groups according to the inhaler device (Seretide Discus [fluticasone 250 mcg, salmeterol 50 mcg], Symbicort Turbuhaler [budesonide 320 mcg, formoterol 9 mcg], and Foradil [formoterol 12 mcg] + Miflonide [budesonide 400 mcg] aerolizer), and compared with 34 healthy controls. Oral and laryngeal regions were examined comprehensively by a rigid telescope. Results: While frequency of oral candidiasis was higher in the group taking budesonide + formoterol by an aerolizer than those of other DPI using groups, frequency of laryngeal candidiasis was more elevated in asthma patients compared to those of healthy controls (p
机译:目的:在这项研究中,我们旨在比较使用含有皮质类固醇和长效β-2激动剂的不同干粉吸入器(DPI)哮喘患者的口腔和喉部发现。方法:这项研究包括109名哮喘患者,根据吸入器装置将其分为3组(Seretide Discus [氟替卡松250 mcg,沙美特罗50 mcg],Symbicort Turbuhaler [布地奈德320 mcg,福莫特罗9 mcg]和Foradil [formoterol 12 mcg] + Miflonide [布地奈德400 mcg]气雾剂),并与34名健康对照组进行比较。用刚性望远镜对口腔和喉部区域进行了全面检查。结果:尽管使用气雾剂服用布地奈德+福莫特罗的组的口腔念珠菌病发生率高于其他使用DPI的组,但与健康对照组相比,哮喘患者的喉部念珠菌病发生率更高(p

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号